DK0709455T3 - Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an - Google Patents
Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved anInfo
- Publication number
- DK0709455T3 DK0709455T3 DK95307748T DK95307748T DK0709455T3 DK 0709455 T3 DK0709455 T3 DK 0709455T3 DK 95307748 T DK95307748 T DK 95307748T DK 95307748 T DK95307748 T DK 95307748T DK 0709455 T3 DK0709455 T3 DK 0709455T3
- Authority
- DK
- Denmark
- Prior art keywords
- humanglicentin
- antibody
- hybridoma
- produce
- assay method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/605—Glucagons
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26656794 | 1994-10-31 | ||
| JP7185272A JP2729159B2 (ja) | 1994-10-31 | 1995-07-21 | ヒトグリセンチンのモノクローナル抗体、この抗体を産生するハイブリドーマおよびそれを用いるヒトグリセンチンの定量法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0709455T3 true DK0709455T3 (da) | 1999-02-22 |
Family
ID=26503007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95307748T DK0709455T3 (da) | 1994-10-31 | 1995-10-31 | Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5712105A (da) |
| EP (1) | EP0709455B1 (da) |
| JP (1) | JP2729159B2 (da) |
| KR (1) | KR960014336A (da) |
| CA (1) | CA2161480A1 (da) |
| DE (1) | DE69504620T2 (da) |
| DK (1) | DK0709455T3 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030082179A1 (en) * | 2001-07-03 | 2003-05-01 | Hutchison James Scott | Parathyroid hormone antibodies and related methods |
| US20080076119A9 (en) * | 2003-12-29 | 2008-03-27 | Lei Sun | Composite organic inorganic nanoclusters |
| US20050191665A1 (en) * | 2003-12-29 | 2005-09-01 | Xing Su | Composite organic-inorganic nanoclusters |
| US20050147963A1 (en) * | 2003-12-29 | 2005-07-07 | Intel Corporation | Composite organic-inorganic nanoparticles and methods for use thereof |
| US7361410B2 (en) * | 2003-12-29 | 2008-04-22 | Intel Corporation | External modification of composite organic inorganic nanoclusters comprising raman active organic compound |
| US20070048797A1 (en) * | 2004-08-11 | 2007-03-01 | Xing Su | Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules |
| US7776547B2 (en) * | 2004-08-26 | 2010-08-17 | Intel Corporation | Cellular analysis using Raman surface scanning |
| US20060147941A1 (en) * | 2004-12-30 | 2006-07-06 | Intel Corporation | Methods and apparatus for SERS assay of biological analytes |
| US20070155022A1 (en) * | 2005-12-30 | 2007-07-05 | Mineo Yamakawa | Degenerate binding detection and protein identification using Raman spectroscopy nanoparticle labels |
| EP3194441A1 (en) | 2014-09-16 | 2017-07-26 | Regeneron Pharmaceuticals, Inc. | Anti-glucagon antibodies and uses thereof |
| SG10201913074WA (en) | 2016-08-30 | 2020-03-30 | Regeneron Pharma | Methods of treating severe insulin resistance by interfering with glucagon receptor signaling |
| WO2018075792A1 (en) | 2016-10-20 | 2018-04-26 | Regeneron Pharmaceuticals, Inc. | Methods of lowering blood glucose levels |
| US12139546B2 (en) | 2017-08-22 | 2024-11-12 | Regeneron Pharmaceuticals, Inc. | Methods of treating urea cycle disorders by interfering with glucagon receptor signaling |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| JPH0523196A (ja) * | 1991-07-17 | 1993-02-02 | Nisshin Flour Milling Co Ltd | ヒトグリセンチンのモノクローナル抗体およびそれを用いるヒトグリセンチンの定量法 |
| JPH0680584A (ja) * | 1992-07-13 | 1994-03-22 | Nisshin Flour Milling Co Ltd | グリセンチンを有効成分とする医薬 |
| JP2961045B2 (ja) * | 1993-02-24 | 1999-10-12 | 日清製粉株式会社 | 腸管粘膜増強促進剤 |
| JP2887060B2 (ja) * | 1993-06-30 | 1999-04-26 | 日清製粉株式会社 | グリセンチンの生産方法 |
-
1995
- 1995-07-21 JP JP7185272A patent/JP2729159B2/ja not_active Expired - Fee Related
- 1995-10-25 US US08/548,152 patent/US5712105A/en not_active Expired - Fee Related
- 1995-10-26 CA CA002161480A patent/CA2161480A1/en not_active Abandoned
- 1995-10-31 DK DK95307748T patent/DK0709455T3/da active
- 1995-10-31 DE DE69504620T patent/DE69504620T2/de not_active Expired - Fee Related
- 1995-10-31 EP EP95307748A patent/EP0709455B1/en not_active Expired - Lifetime
- 1995-10-31 KR KR1019950038363A patent/KR960014336A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0709455B1 (en) | 1998-09-09 |
| KR960014336A (ko) | 1996-05-22 |
| US5712105A (en) | 1998-01-27 |
| JP2729159B2 (ja) | 1998-03-18 |
| JPH08183799A (ja) | 1996-07-16 |
| CA2161480A1 (en) | 1996-05-01 |
| DE69504620D1 (de) | 1998-10-15 |
| DE69504620T2 (de) | 1999-05-06 |
| EP0709455A1 (en) | 1996-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT719859E (pt) | Anticorpo monoclonal anti-alfa v-integrina | |
| DK0941344T3 (da) | Humaniserede anti-CD11a-antistoffer | |
| DK473887D0 (da) | Hybridomacellelinie, monoklonalt antistof, fremgangsmaade til fremstilling af og anvendelse af det monoklonale antistof | |
| DE69920897D1 (de) | Monoklonale antikörper mit verringerter immunisierungsfähigkeit | |
| DK0996728T3 (da) | Forbedrede anti-IgE antistoffer og fremgangsmåde til forbedring af antistoffer | |
| NO962346D0 (no) | Humaniserte antistoffer og anvendelser derav | |
| FI964845L (fi) | CD44v6:n vastaiset monoklonaaliset vasta-aineet | |
| FI960567L (fi) | Monoklonaalinen vasta-aine, joka indusoi apoptoosin | |
| EP0741144A4 (en) | MONOCLONAL ANTIBODY AGAINST ANTIANNEXIN-V, METHOD FOR THE PRODUCTION AND USE THEREOF | |
| DE69738312D1 (de) | Hepatitis b monoklonale antikörper | |
| FI945865L (fi) | Glykoprofeiini P:lle kohdistettuja monoklonaalisia vasta-aineita | |
| DE69828154D1 (de) | Anti-alphavbeta3 humanizierte monoklonale antikörper | |
| DK26587D0 (da) | Monoklonalt antistof, maalemetode for glucosyleret protein ved anvendelse af det monoklonale antistofog kit omfattende dette | |
| PT840620E (pt) | Antagonistas de il-8 para o tratamento de asma | |
| DK557289A (da) | Monoklonalt, fucosylceramiderkendende antistof, dets fremstilling og anvendelse samt hybridoma til fremstillingen | |
| FI972430L (fi) | Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja | |
| NO20004251D0 (no) | Humaniserte anti-CEA monoklonale antistoffer med høy affinitet | |
| EP0922761A4 (en) | MONOCLONAL ANTIBODY, SPECIFIC FOR ANTI-HUMAN FIBRINE MONOMER, METHOD FOR PRODUCING THE SAME, HYBRYDOM CELLS AND AN IMMUNOASSAY METHOD | |
| DE69023717D1 (de) | Monoklonaler Antikörper. | |
| DK0722952T3 (da) | Hypoallergen colostrum-serum-fraktion med høj antistofaktivetet, dens anvendelse og fremgangsmåde til fremstilling af en sådan fraktion | |
| DE69415030D1 (de) | Nucleosid derivate, verfahren zu ihrer herstellung und für diese derivate spezifische monoklonale und polyklonale antikörper | |
| BR1100555B1 (pt) | anticorpos monoclonais humanizados. | |
| NO20000079D0 (no) | Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav | |
| NO985281D0 (no) | Monoklonalt antihumant MP52-antistoff | |
| AU2003204560A1 (en) | Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method |